- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Oculis Holding AG (OCS)
Oculis Holding AG stock price live, this page displays NASDAQ OCS stock exchange data. View the OCS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Oculis Holding AG real time stock price chart below.
What Is the Oculis Holding AG Stock Price Today?
The Oculis Holding AG stock price today is 19.480.
What Is the Stock Symbol for Oculis Holding AG?
The stock ticker symbol for Oculis Holding AG is OCS.
Is OCS the Same as $OCS?
$OCS is a common way to refer to the Oculis Holding AG ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Oculis Holding AG Trade On?
Oculis Holding AG is listed and trades on the NASDAQ stock exchange.
Is Oculis Holding AG a Good Stock to Buy?
Determining whether Oculis Holding AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Oculis Holding AG share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OCS quote. (ISIN: CH1242303498)
What Is the Oculis Holding AG Stock Price Today?
The Oculis Holding AG stock price today is 19.480.
What Is the Stock Symbol for Oculis Holding AG?
The stock ticker symbol for Oculis Holding AG is OCS.
Is OCS the Same as $OCS?
$OCS is a common way to refer to the Oculis Holding AG ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Oculis Holding AG Trade On?
Oculis Holding AG is listed and trades on the NASDAQ stock exchange.
Is Oculis Holding AG a Good Stock to Buy?
Determining whether Oculis Holding AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Oculis Holding AG share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OCS quote. (ISIN: CH1242303498)
19.480
-0.250(-1.27%)
Closed·
After Hours
19.4800.000(0.00%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.310
19.700
52 wk Range
10.790
23.080
OCS Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
OCS is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.31019.700
52 wk Range
10.79023.080
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
OCS Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
37.469
Upside
+92.34%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings downwards for the upcoming period
Oculis Holding AG Company Profile
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally. The company’s lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease; and OCS-05, a disease modifying neuroprotective agent for neurological damage with indications for glaucoma, dry age-related macular degeneration and diabetic retinopathy, and acute optic neuritis. Oculis Holding AG was formerly known as Oculis SA and changed its name to Oculis Holding AG in March 2023. The company was founded in 2017 and is based in Zug, Switzerland.
Compare OCS to Peers and Sector
Metrics to compare | OCS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOCSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.5x | −1.2x | −0.5x | |
PEG Ratio | 0.19 | 0.00 | 0.00 | |
Price / Book | 5.4x | 1.5x | 2.6x | |
Price / LTM Sales | 1,162.0x | 14.6x | 3.0x | |
Upside (Analyst Target) | 81.6% | 93.5% | 51.9% | |
Fair Value Upside | Unlock | −0.6% | 8.9% | Unlock |
Analyst Ratings
7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 37.469
(+92.34% Upside)
Earnings
Latest Release
May 08, 2025
EPS / Forecast
-0.69 / -0.46
Revenue / Forecast
285.00K / 520.00K
People Also Watch
FAQ
What Is the Oculis Holding (OCS) Stock Price Today?
The Oculis Holding stock price today is 19.48
What Stock Exchange Does Oculis Holding Trade On?
Oculis Holding is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Oculis Holding?
The stock symbol for Oculis Holding is "OCS."
What Is the Oculis Holding Market Cap?
As of today, Oculis Holding market cap is 1.06B.
What Is Oculis Holding's Earnings Per Share (TTM)?
The Oculis Holding EPS (TTM) is -2.38.
From a Technical Analysis Perspective, Is OCS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Oculis Holding Stock Split?
Oculis Holding has split 0 times.
How Many Employees Does Oculis Holding Have?
Oculis Holding has 49 employees.
What is the current trading status of Oculis Holding (OCS)?
As of Jun 20, 2025, Oculis Holding (OCS) is trading at a price of 19.48, with a previous close of 19.48. The stock has fluctuated within a day range of 19.31 to 19.70, while its 52-week range spans from 10.79 to 23.08.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.